EQR
56
2
CNX
65
-3
XYL
49
4
EIX
50
2
WM
70
8
SLG
69
-4
THC
65
-3
CFG
30
-2
AMAT
52
-2
EXPD
45
2
BWA
41
5
AZO
48
5
WU
34
14
TXT
60
-5
MPC
49
-6
SO
55
4
F
47
4
TRV
43
-7
CHD
59
-2
NWS
58
-4
EQR
56
2
CNX
65
-3
XYL
49
4
EIX
50
2
WM
70
8
SLG
69
-4
THC
65
-3
CFG
30
-2
AMAT
52
-2
EXPD
45
2
BWA
41
5
AZO
48
5
WU
34
14
TXT
60
-5
MPC
49
-6
SO
55
4
F
47
4
TRV
43
-7
CHD
59
-2
NWS
58
-4
Financhill
Back

RAPT Therapeutics Quote, Financials, Valuation and Earnings

NOW is the time to get in on this trillion-dollar megatrend

Get it here.
Sell
18

RAPT
RAPT Therapeutics

Last Price:
7.93
Seasonality Move:
33.18%

7 Day Trial

ALL ACCESS PASS

$ 7

$50 trade to make today with huge potential!

Click here to access my #1 options strategy for overnight wins starting with $50!

RAPT Therapeutics Price Quote

$7.93
-0.02 (0%)
(Updated: April 20, 2024 at 3:52 AM ET)

RAPT Therapeutics Key Stats

Sell
18
RAPT Therapeutics (RAPT) is a Sell
Day range:
$7.62 - $7.96
52-week range:
$6.86 - $27.35
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
93.81
P/B ratio:
1.88%
Volume:
787.8K
Avg. volume:
942.7K
1-year change:
-58.79%
Market cap:
$276.6M
Revenue:
$0
EPS:
$-3.05

How Much Does RAPT Therapeutics Make?

Data Unavailable

Is RAPT Therapeutics Growing As A Company?

Data Unavailable

RAPT Therapeutics Stock Price Performance

  • Did RAPT Therapeutics Stock Go Up Last Month?
    RAPT Therapeutics share price went down by -7.99% last month
  • Did RAPT's Share Price Rise Over The Last Year?
    RAPT share price fell by -58.79% over the past 1 year

What Is RAPT Therapeutics 52-Week High & Low?

RAPT Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy RAPT Therapeutics?

  • How Much Debt Does RAPT Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does RAPT Therapeutics Have?
    Cash and short term investments quarterly total is $158.9M
  • What Is RAPT Therapeutics’s Book Value Per Share?
    Book value per share is 4.27

Is RAPT Therapeutics Cash Flow Positive?

  • What Is RAPT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$97M
  • What Is RAPT Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.4M
  • What Is RAPT Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $104.1M

RAPT Therapeutics Return On Invested Capital

Data Unavailable

RAPT Therapeutics Earnings Date & Stock Price

RAPT Therapeutics Competitors

  • Who Are RAPT Therapeutics's Competitors?
    Below is a list of companies who compete with RAPT Therapeutics or are related in some way:
    • Avinger Inc (AVGR)
    • Axsome Therapeutics Inc (AXSM)
    • Emergent BioSolutions Inc (EBS)
    • Skye Bioscience Inc (SKYE)
    • Tonix Pharmaceuticals Holding Corp (TNXP)

RAPT Therapeutics Dividend Yield

Data Unavailable

RAPT Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 6.56%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 22.00
Upside from Last Price: 176.73%

Major Shareholders

  • How many RAPT shares are owned by institutional investors?
    58.1M RAPT shares are owned by institutional investors
  • How many RAPT shares are owned by insiders?
    245.6K RAPT shares are owned by insiders